Dow Down 0.62% Nasdaq Down 1.14%

Enzon Pharmaceuticals Inc. (ENZN)

-NasdaqCM
1.09 Up 0.01(0.93%) 4:00PM EDT
Prev Close:1.08
Open:1.03
Bid:1.10 x 1200
Ask:1.11 x 4100
1y Target Est:14.00
Beta:1.32
Next Earnings Date:N/A
Day's Range:1.02 - 1.14
52wk Range:0.78 - 1.83
Volume:785,620
Avg Vol (3m):692,019
Market Cap:48.10M
P/E (ttm):2.07
EPS (ttm):0.53
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ENZN

Comparison

Symbol% ChgMkt Cap
ENZNUp 0.93%48.10M
ISISDown 3.71%4.79B
NKTRDown 2.26%1.60B
PFEDown 0.72%191.37B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):1.45
Ex-Dividend Date:24-Dec-13

Analysts

Annual EPS Est (Dec-14) :N/A
Quarterly EPS Est (0-00-31) :N/A
Mean Recommendation*:1.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Enzon Pharmaceuticals, Inc. is engaged in licensing drug products. Its marketed drug products include PegIntron for chronic hepatitis C; Sylatron for Melanoma; Macugen for neovascular age-related macular degeneration; CIMZIA for Crohn’s disea... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback